After Lonza announced the collaboration with Ethris to develop spray-dried mRNA vaccines for Respiratory Disease Prevention, European Pharmaceutical Manufacturer spoke to Carsten Rudolph, PhD, co-founder and chief executive officer, Ethris and Kim Shepard, director of advanced drug delivery at Lonza to learn more.
BOY ANTHONY Shutterstock